ELCO Management’s SELLAS Life Sciences SLS Stock Holding History

ELCO Management’s Portfolio SLS Stock Details SLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$61.8K	Hold	14,609	–	–	0.03%	168
2025 Q4	$55.1K	Buy	14,609 +600	+4%	+$1.17K	0.03%	155
2025 Q3	$22.6K	Buy	+14,009	New	+$25K	0.01%	164

Other funds holding SLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

ELCO Management's SLS Position: Q1 2026 in Review

ELCO Management held its SELLAS Life Sciences (SLS) position steady in Q1 2026 at 14,609 shares worth $61.8K. The position accounts for 0.03% of the portfolio, ranked #168.

ELCO Management first reported a position in SLS in Q3 2025 and has held it in 3 quarters since. 160 funds tracked by Wall St. Rank hold SLS as of Q1 2026.

ELCO Management held 14,609 shares of SELLAS Life Sciences worth $61.8K as of Q1 2026.
ELCO Management left its SELLAS Life Sciences share count unchanged in Q1 2026.
SELLAS Life Sciences made up 0.03% of ELCO Management's portfolio in Q1 2026, its #168 holding.
ELCO Management first reported a position in SELLAS Life Sciences in Q3 2025 and has held it in 3 quarters since.
160 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q1 2026.

Based on ELCO Management's 13F filing for Q1 2026, filed 24 Apr 2026.